Table 2.
Demographic characteristics of the patients with infections
| Patient | Age (yr) | BMI (kg/m2) | Underlying disease | Chemo therapy | Radiation therapy | Axillary node dissection | Use of ADM | Drain (day) |
|---|---|---|---|---|---|---|---|---|
| 1 | 40 | 17.10 | Gastric cancer | + | + | SLNB | AlloDerm | 21 |
| 2 | 52 | 20.13 | HBV | - | - | SLNB | AlloDerm | 23 |
| 3 | 45 | 21.49 | - | + | + | ALND | CGCryoDerm | 17 |
| 4 | 66 | 23.80 | DM | + | + | SLNB | CGCryoDerm | 19 |
| 5 | 51 | 23.28 | - | + | - | SLNB | SurgiMend | 14 |
| 6 | 47 | 24.17 | - | - | - | SLNB | MegaDerm | 12 |
| 7 | 53 | 19.71 | - | - | - | SLNB | SurgiMend | 17 |
| 8 | 34 | 28.58 | HTN | + | - | SLNB | SurgiMend | 26 |
BMI, body mass index; ADM, acellular dermal matrix; SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; HBV, hepatitis B virus infection; DM, diabetes mellitus; HTN, hypertension.